Related Experiment Video
Updated: Mar 27, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
A Transformer-Based Deep Learning Model for predicting Early Recurrence in Hepatocellular Carcinoma After Hepatectomy
Hongxiang Li1, Zehong Qiu2, Jing Zhang1
1Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Background:
This study aimed to develop and validate a transformer framework-based deep learning (DL) network using intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) to predict early recurrence in hepatocellular carcinoma (HCC).
Materials And Methods:
This retrospective study included 122 patients with HCC who underwent magnetic resonance imaging examination, including an IVIM-DWI sequence with nine b-values, before resection. These were divided into training (n=85) and test (n=37) sets. A vision transformer (ViT) framework-based DL was developed to predict early recurrence in HCC. Deep features were extracted from nine b-value DWI images and IVIM parametric maps and fused to construct the fused DL (ViT-fDL) prediction model. A clinical model was constructed using multivariate logistic regression analysis. A combined model was constructed using deep features from the ViT-fDL model and clinical independent features. The performances of the models were evaluated by discrimination, calibration, and clinical applicability.
Results:
Among 122 patients (108 males,14 females; mean age, 51.0 ± 11.9 years), 49 (40.1%) experienced early recurrence. The respective areas under the curve for the training and test sets were 0.755 (95% Confidence interval (CI), 0.650-0.842) and 0.764 (95% CI, 0.596-0.887) using the clinical model, 0.968 (95% CI, 0.905-0.994) and 0.815 (95% CI, 0.653-0.923) using the ViT-fDL model, and 0.991 (95% CI, 0.940-1.000) and 0.821 (95% CI, 0.660-0.927) using the combined model.
Conclusion:
The ViT-fDL model based on IVIM can be useful for preoperative prediction early recurrence in HCC. The combined model was a more effective and precise prediction tool than other models, promising to guide individualized postoperative monitoring.
More Related Videos
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024